UHS is a fortune 500 company owning over 300 health facilities, hospitals and behavioral health facilities (these deal with mental health, substance abuse, schizophrenic, etc) across the USA and UK...
The company has grown its revenues and earnings significantly over the previous 5 years, they have grown earnings by 50%... Earnings per share over the past 6 years has grown immensly from $9.16 per share in 2019 to $23.42 in 2025. This has been benefitted by the companies immense share buyback programme, betting itself on future growth.
UHS' balance sheet has remained stable in recent history, debt has grown over the last 5 years, from $4.56 to $5.17B, but this is to be expected after the company has returned massive growth in EPS and revenues. The company continues to hold a cash positon of $100-150M.
The company has several large tailwinds... The aging US population will require more health facilities as they get older. Growing chronic diseases. The company has many facilities in parts of the US where there is expected to be high growth in population and thus demand - Texas, Florida, California, Nevada, although the company has exposure across the country.
UHS is currently hovering around it's 52W low, with a potential 74.5% upside back to it's previous high in December, less than 7 months ago.
Why has the stock price dropped so significantly in 2026? It comes down to a few reasons... The purchase of TalkSpace for almost $1B has created some uncertainties. Changing policies of Medicare and Medicade programs which contribute a significant portion of UHS' revenues. Other regulatory changes, such as those introduced on July 4 2025 - which "attaches work and community service requirements to eligibility for Medicaid benefits". The potential increase of interest rates, the company holds some debt (in order to rapidly grow), therefore will have to pay more interest if the rates rise compressing margins. The outcome of upcoming court cases which can make UHS pay out money, which is something almost every company in healthcare has to deal with.
Reflecting on the risk factors of the company, they are mostly (IMO) short term risks that likely will not affect the longterm profitability of the company.
The company offers dividends, which has stayed at $0.20 per share for a number of years, a 0.57% annual return at current prices. The company focuses on buybacks which have ranged from 4% to 11% from 2019 to 2025, which boost EPS and are a bet on themselves. The company has a large insider ownership of over 16%, the company is very interested in giving back to shareholders.
UHS is a solid hedge against the tech sector and the 'AI bubble', still providing high growth, an exceptional level of buybacks and a stable dividend at a 52 week low and a 75% upside back to previous highs 7 months ago.
Not financial advice.